Hepatitis SA acknowledges and respects the Kaurna people as the traditional custodians of the unceded ancestral land from which we work. We pay our respects to elders past and present.
Ten years ago, on 1 March 2016, Australia became the first country to publicly subsidise new direct-acting antiviral (DAA) hepatitis C treatments for the entire population, no matter their condition or location.
The success of this has been dramatic:
Announcing the $1 billion funding just before Christmas in 2015, the then federal health minister for Health Sussan Ley described the listing of the drugs on the Pharmaceutical Benefits Scheme (PBS) as a “watershed moment”. Continue reading.
In this issue: Hep B Birth Dose | Jeff Steward Farewell | Spreading the Word | Hep D Basics | Closing the Gap in Practice | Reducing BBVs in Regional SA | Intertwined | Unsung Hep Hero | In Our Library | Contacts
Australia's leading hepatitis researchers and clinicians have released a joint statement backing ATAGI advice on hepatitis B vaccinations.
In this issue: High Hep C Cure Rate among NSP Clients |A Call to Action for nurses and midwives | Hep C & Mental Illness: New Link discovered | How Hep B Research Helped when COVID-19 Hit | SA Nurses Say Get Tested | Can a Parent's HBV Affect Their Newborn's Heart? | In Our Library: Life after hepatitis C | Wait! There's more...
Hepatitis Australia and ASHM are urging Australians to maintain routine hepatitis B vaccinations for newborns.
Recent changes to the processing of pathology reports for My Health Record has elevated the importance of pre-test counselling around implications of test results, where to go for further information, and confidentiality.
In this issue: Testing Saves Lives |Malhotra Syndrome - what is it? | What SA did during World Hep Day | DAA Hep C cure rates | Hep B treatment: good & bad news | Supporting families who support users | In Our Library
Understanding hepatitis A, B and C may not be quite as simple as ABC, but a session with Hepatitis SA's highly skilled educators will certainly help you get there.
In this information age it is ironic that credible, reliable information can sometimes be hard to find in the tsunami of results from online searches.
Guide to South Australian community pharmacies which dispense the new hepatitis C medicines.
Hepatitis is inflammation of the liver. It can be brought on by alcohol, drugs, viruses and other toxins. Viral hepatitis refers to hepatitis resulting from infection of the liver by the hepatitis A, B, C, D or E viruses - hepatitis A, B and C being the most common. These viruses all produce similar symptoms, but differ in modes of transmission and long-term effects on health.
Hepatitis B is spread through blood, sexual fluids and from mother to child during birth. If left unmanaged, it can lead to cirrhosis and liver cancer. Effective treatments are available.
An estimated 257 million people are living with chronic hepatitis B worldwide - 226,000 of them in Australia.
Hepatitis C is transmitted via blood-to-bloodstream contact. Untreated, hepatitis C can lead to cirrhosis and serious liver disease. Hepatitis C can be cured.
World-wide, there are an estimated 71 million people living with chronic hepatitis C - 130,000 of them in Australia.
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C. This includes people with hepatitis B or C, their family and friends, and professionals who support them. We also provide hepatitis C peer education and support services, SA Harm Reduction Peer Services, and operate a NSP secondary site.
